Skip to main content
. 2022 Mar 29;12:863655. doi: 10.3389/fonc.2022.863655

Figure 2.

Figure 2

Actuarial prostate-specific antigen (PSA) relapse in 444 organ-confined primary prostate cancer treated with rectal distension-mediated 5 × 9 Gy SABR. Patient groups are defined as combined low-risk and favorable intermediate-risk (FIR), unfavorable intermediate-risk (UIR), and high-risk (High) patients.